Healthcare Global Enterprises Limited (HCG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Healthcare Global Enterprises Limited (HCG) has a cash flow conversion efficiency ratio of 0.193x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.92 Billion ≈ $20.79 Million USD) by net assets (Rs9.94 Billion ≈ $107.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HCG defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Healthcare Global Enterprises Limited - Cash Flow Conversion Efficiency Trend (2011–2026)
This chart illustrates how Healthcare Global Enterprises Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Healthcare Global Enterprises Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Healthcare Global Enterprises Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Horizon Bancorp
NASDAQ:HBNC
|
0.030x |
|
Southside Bancshares, Inc.
NYSE:SBSI
|
0.057x |
|
CBL & Associates Properties Inc
NYSE:CBL
|
0.204x |
|
Verve Therapeutics Inc
NASDAQ:VERV
|
-0.059x |
|
Shenzhen Shenbao Industrial Co Ltd
SHE:000019
|
0.106x |
|
Lintes Technology Co Ltd
TW:6715
|
-0.004x |
|
Nitratos de Chile SA
SN:NITRATOS
|
0.085x |
|
Burford Capital Ltd
NYSE:BUR
|
-0.026x |
Annual Cash Flow Conversion Efficiency for Healthcare Global Enterprises Limited (2011–2026)
The table below shows the annual cash flow conversion efficiency of Healthcare Global Enterprises Limited from 2011 to 2026. For the full company profile with market capitalisation and key ratios, see Healthcare Global Enterprises Limited market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs14.10 Billion ≈ $152.51 Million |
Rs3.47 Billion ≈ $37.54 Million |
0.246x | -23.15% |
| 2025-03-31 | Rs9.90 Billion ≈ $107.07 Million |
Rs3.17 Billion ≈ $34.29 Million |
0.320x | -2.63% |
| 2024-03-31 | Rs8.65 Billion ≈ $93.56 Million |
Rs2.85 Billion ≈ $30.78 Million |
0.329x | +13.67% |
| 2023-03-31 | Rs8.69 Billion ≈ $94.02 Million |
Rs2.52 Billion ≈ $27.21 Million |
0.289x | +16.17% |
| 2022-03-31 | Rs8.84 Billion ≈ $95.57 Million |
Rs2.20 Billion ≈ $23.81 Million |
0.249x | +47.57% |
| 2021-03-31 | Rs7.14 Billion ≈ $77.22 Million |
Rs1.21 Billion ≈ $13.03 Million |
0.169x | -45.55% |
| 2020-03-31 | Rs4.20 Billion ≈ $45.40 Million |
Rs1.30 Billion ≈ $14.07 Million |
0.310x | +64.35% |
| 2019-03-31 | Rs5.22 Billion ≈ $56.47 Million |
Rs985.04 Million ≈ $10.65 Million |
0.189x | +11.67% |
| 2018-03-31 | Rs5.79 Billion ≈ $62.62 Million |
Rs978.13 Million ≈ $10.58 Million |
0.169x | -9.29% |
| 2017-03-31 | Rs4.90 Billion ≈ $53.00 Million |
Rs912.79 Million ≈ $9.87 Million |
0.186x | +16.66% |
| 2016-03-31 | Rs4.59 Billion ≈ $49.59 Million |
Rs731.97 Million ≈ $7.92 Million |
0.160x | -44.47% |
| 2015-03-31 | Rs2.08 Billion ≈ $22.44 Million |
Rs596.53 Million ≈ $6.45 Million |
0.287x | +57.70% |
| 2014-03-31 | Rs2.82 Billion ≈ $30.51 Million |
Rs514.22 Million ≈ $5.56 Million |
0.182x | +73.35% |
| 2013-03-31 | Rs2.96 Billion ≈ $32.01 Million |
Rs311.26 Million ≈ $3.37 Million |
0.105x | +4206.51% |
| 2012-03-31 | Rs2.19 Billion ≈ $23.73 Million |
Rs-5.62 Million ≈ $-60.78K |
-0.003x | -102.04% |
| 2011-03-31 | Rs1.76 Billion ≈ $19.08 Million |
Rs221.98 Million ≈ $2.40 Million |
0.126x | -- |
About Healthcare Global Enterprises Limited
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncol… Read more